Table 1.
Overall cohort (n=112) | Patients subsequently randomised (n=50) | ||
---|---|---|---|
Sex (male) | 101 (90%) | 46 (92%) | |
Age at registration (years) | 61·7 (5·3) | 61·5 (4·4) | |
WHO performance status score | |||
0 | 34 (30%) | 19 (38%) | |
1 | 68 (61%) | 28 (56%) | |
Unknown | 10 (9%) | 3 (6%) | |
Method of histological diagnosis | |||
Abram's needle or blind biopsy | 2 (2%) | 0 (0%) | |
CT or ultrasound guided | 27 (24%) | 10 (20%) | |
Surgical | 76 (68%) | 38 (76%) | |
Other* | 3 (3%) | 2 (4%) | |
Unknown | 4 (4%) | 0 (0%) | |
Histological subtype | |||
Epithelioid | 83 (74%) | 40 (80%) | |
Sarcomatoid | 3 (3%) | 0 (0%) | |
Mixed or biphasic | 12 (11%) | 7 (14%) | |
Unknown on first relapse | 14 (13%) | 3 (6%) |
Data are number (%) or mean (SD). Percentages do not sum to 100 in some cases because of rounding.
Aspiration cytology (n=1), cytology (tumour block; n=1), and pleural effusion (n=1).